Home / Pomalidomide / Ireland
IE ATC L04AX06 · updated 2 Nov 2026
Pomalidomide shortage in Ireland
Is there a Pomalidomide shortage in Ireland?
Yes. As of 2 Nov 2026, 4 Pomalidomide products are reported short in Ireland, the first since 9 Oct 2026. The company estimate for the return is 6 Nov 2026 (latest 15 Mar 2027). Main reason: manufacturing problem.
Also short in France, Italy, Czechia, Norway, Sweden. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Pomalidomide Teva 2 mg Capsule, hard | TEVA GmbH | 9 Oct 2026 | 15 Mar 2027 | Manufacturing problem Manufacturing delay |
| IE | Pomalidomide Teva 3 mg Capsule, hard | TEVA GmbH | 9 Oct 2026 | 6 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Pomalidomide Teva 1 mg Capsule, hard | TEVA GmbH | 1 Nov 2026 | 6 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Pomalidomide Teva 4 mg Capsule, hard | TEVA GmbH | 1 Nov 2026 | 6 Nov 2026 | Manufacturing problem Manufacturing delay |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.